Clinical trial
Clinical Outcome Following Reinjection of Ranibizumab in Recurrent Cases With Retinopathy of Prematurity
NCT04539106 is registered in ClinicalTrials.gov with Ameera Gamal Abdelhameed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Outcome Following Reinjection of Ranibizumab in Recurrent Cases With Retinopathy of Prematurity
- Lead sponsor
- Ameera Gamal Abdelhameed
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2019
- Completion date
- February 1, 2020
- Enrollment
- 115 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.